LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 146 filers reported holding LOXO ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $14,109,000 | -51.1% | 100,728 | -40.4% | 0.00% | -50.0% |
| Q3 2018 | $28,854,000 | +194.2% | 168,908 | +198.7% | 0.01% | +200.0% |
| Q2 2018 | $9,809,000 | +48.2% | 56,542 | -1.4% | 0.00% | +100.0% |
| Q1 2018 | $6,620,000 | +20.2% | 57,373 | -12.3% | 0.00% | 0.0% |
| Q4 2017 | $5,508,000 | +621.9% | 65,431 | +697.9% | 0.00% | – |
| Q3 2017 | $763,000 | -82.6% | 8,200 | -85.0% | 0.00% | -100.0% |
| Q2 2017 | $4,395,000 | +99.3% | 54,800 | +4.6% | 0.00% | 0.0% |
| Q1 2017 | $2,205,000 | -28.5% | 52,400 | -45.4% | 0.00% | 0.0% |
| Q4 2016 | $3,083,000 | +53.2% | 96,004 | +24.9% | 0.00% | – |
| Q3 2016 | $2,012,000 | +38.1% | 76,867 | +22.3% | 0.00% | – |
| Q2 2016 | $1,457,000 | +7185.0% | 62,861 | +8691.7% | 0.00% | – |
| Q1 2016 | $20,000 | +33.3% | 715 | +36.5% | 0.00% | – |
| Q4 2015 | $15,000 | -99.5% | 524 | -99.7% | 0.00% | -100.0% |
| Q2 2015 | $2,993,000 | – | 166,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |